APOC3, apolipoprotein C3, 345

N. diseases: 153; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Insulin-Dependent
0.270 GeneticVariation disease BEFREE Because serum levels of APOC3 predicted incident CVD events in the CACTI study, inhibiting APOC3 might reduce CVD risk in T1DM patients. 31295146 2019
Diabetes Mellitus, Insulin-Dependent
0.270 Biomarker disease BEFREE These impactful mouse studies were supported by the initial finding that APOC3 predicted coronary artery disease events in participants of the prospective Coronary Artery Calcification in Type 1 Diabetes study with normal TG levels. 31449060 2019
Diabetes Mellitus, Insulin-Dependent
0.270 Biomarker disease BEFREE Interestingly, in a type-1 diabetes rat model lowering of apoCIII delays onset of diabetes. 27875339 2017
Diabetes Mellitus, Insulin-Dependent
0.270 Biomarker disease RGD Lowering apolipoprotein CIII delays onset of type 1 diabetes. 21670290 2011
Diabetes Mellitus, Insulin-Dependent
0.270 GeneticVariation disease BEFREE An APOC3 promoter haplotype has been previously associated with type 1 diabetes. 21373834 2011
Diabetes Mellitus, Insulin-Dependent
0.270 GeneticVariation disease BEFREE We therefore hypothesize haplotypes within the apoCIII gene are associated with type 1 diabetes. 16505251 2006
Diabetes Mellitus, Insulin-Dependent
0.270 AlteredExpression disease BEFREE In the DCCT/EDIC cohort of patients, there was an independent positive association of apoCIII level with microvascular complications of Type 1 diabetes. 15642486 2005
Diabetes Mellitus, Insulin-Dependent
0.270 GeneticVariation disease BEFREE The current study investigated apoCIII protein and apoCIII gene variation in a normotriglyceridemic (82 +/- 57 mg/dL) population of patients with type 1 diabetes, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications (DCCT/EDIC) cohort. 15375785 2004